Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Docetaxel in First-line NSCLC
NCT00145418Phase 2Terminated
- Sponsor
- Oncology Specialists
- Start
- Feb 2005
- Primary completion
- Aug 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin in non-small cell lung cancer (NSCLC), sponsored by Oncology Specialists. Primary endpoint: Response Rate. Started Feb 2005; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00145418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145418.